International conference on harmonisation. Guideline on dose selection for carcinogenicity studies of pharmaceuticals; availability. Fed . Register1995; 60(40): 11278-81.
2.
Goldsworthy TL et al. Assessing proliferation and apoptosis in liver tumor development. CIIT Activities1995; 15: 1-9.
3.
IRDC-Project No. 367-005.Carcinogenicity study in mice. Dated 08 Oct. 1980.
4.
Croy RGRole of chemically induced cell proliferation in carcinogenesis and its use in health risk assessment. Environ Health Perspect1993; 101(Supp 5): 289-302.
5.
Cohen SM, Ellwein LBCell proliferation in carcinogenesis. Science1990; 249: 1007-11.
6.
Schulte-Hermann R. et al. Adaptive response of rat liver tc the gestagen and anti-androgen cyproterone acetate and other inducers. II. Induction of growth Chem Biol Interact1980; 31: 278-86.
7.
Schulte-Hermann R.Tumor promotion in the liver. Arch Toxicol1985; 57: 147-58.
8.
Schuppler J. , Günzel P.Liver tumors and steroid hormones in rats and mice. Arch Toxicol1979; Suppl. 2: 181-95.
9.
Schering IRDC-Project No. 367-004.Carcinogenicity study in rats. Dated 01 October 1979 .
